Back to search
Hereditary Red Blood Cell Disorder (Disorder)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Red Blood Cell Disorder (Disorder) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Red Blood Cell Disorder (Disorder) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or w…
This is a Phase 2a study to evaluate the safety and pharmacokinetics (PK) of luspatercept in pediatric participants with β-thalassemia. The study will be condu…
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignan…
Question: How effective is fortified iodized salt with folic acid (FISFA) in increasing serum and red blood cell folate in non-lactating, non-pregnant women of…
The purpose of this study is to collect and store samples and health information for current and future research to learn more about the causes and treatment of…
The purpose of this research study is to look at genes and determine how they interact with each other to find changes that could explain why some people's immu…
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sic…
The overall objective of this study is to evaluate the effectiveness and safety of transfusing hypoxic red blood cells manufactured with the Hemanext ONE system…